BCL2 and B-cell chronic lymphocytic leukemia: Different aberrant mechanisms lead to the overexpression of BCL2 in the primary phase of CLL tumorigenesis, among which the loss of miR-15 and miR-16 at 13q14, which is detectable in 40–60% of CLL patients and hypomethylation of the BCL2 gene [121,122].